Previous 10 | Next 10 |
home / stock / imexf / imexf news
A recent study has found a clear link between a higher risk of dying from illnesses of the heart and blood vessels and the duration and frequency of unconscious wakefulness throughout night-time sleep. The researchers discovered that in comparison with the general female population, wome...
The i/Blue Imaging System’s(TM) development is the first to harness the power of white light and blue light visualization techniques with the added capability of displaying multiple images simultaneously which will help surgeons perform more accurate tumor resections Imagin...
Imagin Medical (CSE: IME) (OTCQB: IMEXF) , a surgical imaging company, is advancing its proprietary and patented i/Blue(TM) Imaging System. Imagin’s goal is to reduce the cost of treatment for patients with bladder cancer while also improving their chances of survival. Its solution &...
A study done by researchers from the McGovern Medical School and the UTHealth School of Biomedical Informatics has found a likely reason why some cancer treatments that eliminate cancerous cells in mouse research models aren’t as effective during human trials. The study was reported i...
Imagin Medical (CSE: IME) (OTCQB: IMEXF) , a surgical imaging company, has hailed its first product, the i/Blue(TM) Imaging System, as a breakthrough technology that will advance the accuracy and efficiency of bladder cancer detection and removal, thus helping it capture some market share. ...
Researchers from Harvard, MIT, the Ragon Institute of MGH, Brigham and Women’s Hospital and Massachusetts General Hospital recently conducted a study that discovered that the new mRNA coronavirus vaccines were highly efficacious in producing antibodies against the SARS-CoV-2 virus in ...
VANCOUVER, B.C. / BOSTON, March 16, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today reported continued progress towards commercial-stage ma...
Vancouver, B.C. and Boston, MA, Feb. 18, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD3) (“Imagin” or the “Company”) today announced that, further to its press releas...
VANCOUVER, British Columbia, and BOSTON, Jan. 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical Inc. (CSE: IME) (OTCQB: IMEXF) (FSE: DPD2) ("Imagin" or the "Company") is pleased to announce that it has engaged San Diego Torrey Hills Capital, Inc. ("Torrey Hills Capital")...
VANCOUVER, British Columbia, and BOSTON, Jan. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Imagin Medical (CSE: IME) (OTC: IMEXF) (FRA: DPD2) (the “Company”) announces that critical milestones met in the second half of 2020 will support the Company in achieving its 2...
News, Short Squeeze, Breakout and More Instantly...
2024-03-27 17:08:02 ET Surgical imaging for bladder cancer Imagin Medical is a surgical imaging company. They're focusing on establishing a new standard of care in visualizing cancer during minimally invasive surgeries. The Company’s initially focused on bladder ca...
Ponce Therapeutics Executes Worldwide Exclusive License to Speratum Biopharma's Nano-in™ and No-Pass Mimic™ Nanoparticle Technologies in Anti-Aging and Other Products Initially for Skin PR Newswire Ponce Therapeutic's (" Ponce ") lead product, ReBea...
Imagin Medical Announces Stock Option Grants PR Newswire VANCOUVER , BC and BOSTON , April 22, 2022 /PRNewswire/ -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) ( Frankfurt & Stuttgart Symbol: DPD2) ("Imagin" or the "Company") today...